Skip to content

Tag: Sandoz

Explore our medication guides and pharmacology articles within this category.

When did FIRAZYR go generic? The Timeline of Icatibant's Market Entry

3 min read
On July 15, 2019, the patent for the brand-name drug FIRAZYR (icatibant injection) officially expired in the United States, which paved the way for generic versions. The answer to the question, 'When did FIRAZYR go generic?' is not a single date but a series of launches that began shortly after its patent lapsed.

Who Makes Glatiramer Acetate Injections?: A Manufacturer Guide

3 min read
The market for glatiramer acetate injections, a key treatment for multiple sclerosis, was initially dominated by Teva's brand-name product, Copaxone. However, with patent expirations and challenges, several companies have entered the market, offering generic alternatives. Discover who makes glatiramer acetate injections and learn about the competitive landscape that has emerged.